A Study of ITC-6146RO in Patients With Advanced or Metastatic Cancer Who Have Failed Standard Therapy

NCT07423117 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer
Non-small Cell Lung Cancer
Triple Negative Breast Cancer
Metastatic Solid Tumor

Interventions

DRUG: ITC-6146RO

Sponsor

IntoCell, Inc